Stay updated on Telisotuzumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new trial site Grand Hopital de Charleroi - Les Viviers (ID# 234178) was added with a Completed status on 2026-06-01, following earlier entries showing the site as Recruiting/Active, not recruiting on 2026-05-19 and 2026-05-22.
    Difference
    0.1%
    Check dated 2026-06-01T19:21:05.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Two study sites were updated: Ordensklinikum Linz Elisabethinen and Hospital Pablo Tobón Uribe progressed from Recruiting to Completed, indicating they are no longer enrolling participants as of mid-May 2026; the changes reflect recruitment status updates over the 14–22 May 2026 period.
    Difference
    0.1%
    Check dated 2026-05-25T16:39:28.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    New recruitment sites were added (e.g., UZ Gent in Belgium and Hospital Sirio Libanes in Sao Paulo) and the total number of locations is updated to 317, reflecting expanded global participation. Expanded Access status is shown as Temporarily not available and older contact entries were removed.
    Difference
    0.4%
    Check dated 2026-05-18T13:01:42.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The site footer revision number has been updated from v3.5.2 to v3.5.3, reflecting a minor platform/document version update rather than any change to the clinical study information.
    Difference
    0.0%
    Check dated 2026-04-27T07:33:04.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Vienna study sites are now listed with Completed status and specific postal codes; a Nouvelle-Aquitaine site (Pessac) was removed and a New Aquitaine site (Pessac) was added.
    Difference
    0.4%
    Check dated 2026-04-20T02:16:55.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    A new site, Clinica Amo - Rio Vermelho in Salvador, Bahia (ID 231604), was added and marked as Completed on 2026-04-08, updating the ZIP code to 41950-640 and replacing the previous Recruiting entry at 41950-610.
    Difference
    0.1%
    Check dated 2026-04-13T01:08:15.000Z thumbnail image

Stay in the know with updates to Telisotuzumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page.